Ivermectin, Mebendazole i Fenbendazole Protokol za liječenje raka je objavljen i recenziran 19. rujna 2024.

Arna Šebalj

Provjera tvrdnje: Ivermectin, Mebendazole, i Fenbendazole Protokol za liječenje raka

<p>Tvrdnja da je protokol za liječenje raka s ivermektinom, mebendazolom i fenbendazolom objavljen i recenziran 19. rujna 2024. je netočna. Nema znanstvenih dokaza koji podupiru tvrdnju da je ovaj protokol siguran ili učinkovit.</p>
<p>Ivermektin, mebendazol i fenbendazol su lijekovi koji se tradicionalno koriste za liječenje parazitskih infekcija. Iako postoje neke studije koje sugeriraju da ovi lijekovi mogu imati antikancerogene učinke, nema dovoljno dokaza da bi se mogli preporučiti kao standardna terapija za liječenje raka.</p>
<p>Američka agencija za hranu i lijekove (FDA) i Europska agencija za lijekove (EMA) nisu odobrile upotrebu ovih lijekova za liječenje raka. Nadalje, nema znanstvenih članaka objavljenih u recenziranim časopisima koji potvrđuju sigurnost i učinkovitost ovog protokola.</p>
<p>Za sada, standardne terapije za liječenje raka uključuju kirurgiju, kemoterapiju, zračenje i imunoterapiju. Pacijenti s rakom trebaju se konsultirati s liječnicima kako bi odabrali najbolju terapiju za svoje stanje.</p>
<p>Zaključak: Tvrdnja da je protokol za liječenje raka s ivermektinom, mebendazolom i fenbendazolom objavljen i recenziran 19. rujna 2024. je netočna. Nema znanstvenih dokaza koji podupiru tvrdnju da je ovaj protokol siguran ili učinkovit.</p>

<h2>Introduction</h2>
<p>A recent article published on October 16, 2024, claims that a peer-reviewed study in the International Journal of Orthomolecular Medicine shows that ivermectin, mebendazole, and fenbendazole are effective treatments for cancer. This claim has garnered significant attention, particularly in the context of alternative medicine and the COVID-19 pandemic.</p>
<h2>The Claim</h2>
<p>The article states that Drs. William Makis, Paul Marik, Ilyes Baghli, and other scientists from the Frontline COVID-19 Critical Care Alliance (FLCCC) conducted a study demonstrating the anticancer benefits of these three deworming drugs. The study was published on September 19, 2024, and suggests that these drugs could be a breakthrough in cancer treatment, potentially replacing conventional treatments like chemotherapy and radiation.</p>
<h2>Analysis of the Claim</h2>
<p>The International Journal of Orthomolecular Medicine is a reputable source, and the study was peer-reviewed, which adds credibility to the claim. However, it is important to note that a single study, even if peer-reviewed, does not constitute definitive proof. Further research and clinical trials are necessary to validate these findings and determine the safety and efficacy of these drugs for cancer treatment.</p>
<p>Ivermectin, mebendazole, and fenbendazole are primarily used as antiparasitic drugs. While there is some preliminary evidence suggesting their potential anticancer properties, the mechanisms by which they might work against cancer are not fully understood. More studies are needed to explore these mechanisms and to assess the long-term effects of these drugs on cancer patients.</p>
<h2>Related Studies and Evidence</h2>
<p>Several studies have explored the potential of ivermectin and other antiparasitic drugs in cancer treatment. For example, a study published in the journal <a href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.717529/full">Frontiers in Pharmacology </a>suggests that ivermectin m ay have anticancer effects by inhibiting certain cellular pathways. Similarly, a review in the journal <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4096024/">Cancers</a> &nbsp;discusses the potential of mebendazole as an anticancer agent.</p>
<p>However, these studies are preliminary, and more extensive clinical trials are needed to confirm the efficacy and safety of these drugs in cancer treatment.</p>
<h2>Conclusion</h2>
<p>While the claim that ivermectin, mebendazole, and fenbendazole are effective cancer treatments is based on a peer-reviewed study, it is premature to conclude that these drugs are a definitive solution for cancer. Further research and clinical trials are necessary to validate these findings and to ensure the safety and efficacy of these treatments. Patients should consult with their healthcare providers before considering any alternative treatments.</p>

Claim Review: Effectiveness of Ivermectin, Mebendazole, and Fenbendazole as Cancer Treatments

<h2>Introduction</h2>
<p>A recent article published on October 16, 2024, claims that a peer-reviewed study in the International Journal of Orthomolecular Medicine shows that ivermectin, mebendazole, and fenbendazole are effective treatments for cancer. This claim has garnered significant attention, particularly in the context of alternative medicine and the COVID-19 pandemic.</p>
<h2>The Claim</h2>
<p>The article asserts that Drs. William Makis, Paul Marik, Ilyes Baghli, and other scientists from the Frontline COVID-19 Critical Care Alliance (FLCCC) have conducted a study demonstrating the anticancer benefits of these three deworming drugs. The study suggests that these drugs could be a viable alternative to conventional cancer treatments like chemotherapy and radiation.</p>
<h2>Analysis of the Claim</h2>
<p>The study published in the International Journal of Orthomolecular Medicine is indeed peer-reviewed, which lends some credibility to the claim. However, it is important to note that a single study, even if peer-reviewed, does not constitute definitive proof of a treatment's effectiveness. Further research and replication of the study's findings are necessary to establish the drugs' efficacy as cancer treatments.</p>
<p>Ivermectin, mebendazole, and fenbendazole are primarily used as antiparasitic medications. While there is some preliminary evidence suggesting that these drugs may have anticancer properties, the mechanisms by which they might work against cancer are not fully understood. More research is needed to determine the safety and efficacy of these drugs in cancer treatment.</p>
<p>The article also mentions the concept of 'turbo cancer,' which is not a widely recognized medical term. The claim that COVID-19 vaccines are linked to an increase in cancer cases is not supported by scientific evidence and should be approached with caution.</p>
<h2>Conclusion</h2>
<p>While the study published in the International Journal of Orthomolecular Medicine is a promising development, it is too early to conclude that ivermectin, mebendazole, and fenbendazole are effective cancer treatments. More research is needed to validate these findings and to understand the potential risks and benefits of using these drugs in cancer therapy. Patients should consult with their healthcare providers before considering any alternative treatments.</p>
<h2>References</h2>
<ul>
  <li><a href="https://pubmed.ncbi.nlm.nih.gov/32942671/">Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?</a>&nbsp;</li>
  <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6769799/">Mebendazole as a Repurposed Agent in Cancer Therapy</a>&nbsp;</li>
  <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7458798/">Fenbendazole: A Broad-Spectrum Anthelmintic Drug with Potential Anticancer Activity</a>&nbsp;</li>
</ul>

<p>In recent years, the drugs Ivermectin, Mebendazole, and Fenbendazole have gained significant attention, particularly among conspiracy theorists. This article aims to provide a comprehensive overview of these drugs, their intended uses, and the controversies surrounding them.</p>
<h2>Understanding the Drugs</h2>
<h3>Ivermectin</h3>
<p>Ivermectin is an anti-parasitic medication commonly used to treat various parasitic infections, including river blindness and strongyloidiasis. It has been approved by the FDA for specific uses and has a well-established safety profile when used appropriately. However, its use has become a subject of debate due to claims about its efficacy against viral infections, particularly COVID-19.</p>
<h3>Mebendazole</h3>
<p>Mebendazole is another anti-parasitic drug used to treat infections caused by worms, such as pinworms, roundworms, and hookworms. It is widely used in veterinary medicine and has been approved for human use in certain cases. Like Ivermectin, Mebendazole has been the subject of unproven claims regarding its effectiveness against various diseases.</p>
<h3>Fenbendazole</h3>
<p>Fenbendazole is primarily used in veterinary medicine to treat parasitic infections in animals. It is not approved for human use, but it has gained attention due to anecdotal reports and unverified claims about its potential benefits for humans. The lack of clinical trials and regulatory approval makes its use in humans highly controversial.</p>
<h2>The Rise of Misinformation</h2>
<p>The surge in interest in these drugs can be attributed to several factors, including the spread of misinformation on social media and the internet. Conspiracy theorists often promote these drugs as miracle cures for various ailments, despite the lack of scientific evidence supporting these claims. The COVID-19 pandemic has exacerbated this trend, with many people desperate for treatments and willing to try unproven remedies.</p>
<h2>Scientific Evidence and Regulatory Stance</h2>
<p>The scientific community and regulatory bodies have been vocal about the lack of evidence supporting the use of these drugs for unapproved indications. The FDA and other health organizations have issued warnings against the use of Ivermectin, Mebendazole, and Fenbendazole for treating COVID-19 or other viral infections. Clinical trials and meta-analyses have failed to provide conclusive evidence of their efficacy in these contexts.</p>
<h2>The Importance of Evidence-Based Medicine</h2>
<p>The controversy surrounding these drugs highlights the importance of evidence-based medicine. Relying on scientific research and clinical trials ensures that treatments are safe and effective. Patients should consult healthcare professionals before starting any new medication, especially those not approved for human use or for unapproved indications.</p>
<h2>Conclusion</h2>
<p>The recent interest in Ivermectin, Mebendazole, and Fenbendazole among conspiracy theorists underscores the need for accurate information and evidence-based medicine. While these drugs have approved uses, their promotion for unproven indications can be dangerous. It is crucial for individuals to seek reliable sources of information and consult healthcare professionals before making decisions about their health.</p>
<h2>References</h2>
<ol>
  <li>FDA. (2021). Why You Should Not Use Ivermectin to Treat or Prevent COVID-19. Retrieved from <a href="https://www.fda.gov/consumers/health-fraud-scams/fraudulent-coronavirus-disease-2019-covid-19-products">FDA Website</a>&nbsp;</li>
  <li>World Health Organization. (2021). WHO advises that ivermectin only be used to treat COVID-19 within clinical trials. Retrieved from <a href="https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials">WHO Website</a></li>
  <li>Centers for Disease Control and Prevention. (2021). Parasites - Mebendazole. Retrieved from <a href="https://www.cdc.gov/sth/about/index.html">CDC Website</a>&nbsp;</li>
</ol>

The Controversy Surrounding Ivermectin, Mebendazole, and Fenbendazole

If you want to replace an existing title on a portal and you want the replaced title to be visible to you and your followers.

Move the mouse over the title and make a right click.

Select Remedia -> Alternate Title from the menu

In the pop-up window, enter a new title that you like.

The blue icon copies the existing title into the input field, so you don't have to type everything...

By pressing Submit, the title will be replaced, which will be visible to you and others who visit the pages.

(There is a possibility that you will have to reload the page for the changes to be visible)

You can contact one of the fact-checking organizations.

Claim rated as -> Choose from false to true

Add claimer -> Opens a pop-up window that allows you to search for existing people already registered in the system or to create a new profile of that person.

Claimed At -> Enter the link to the page where the claim was found. You can add more places and link more claim authors

Short description -> short content that is seen when sharing articles on social networks

Field for entering the content of the article.

After the article is published, it will be visible on the Remedia social network and to everyone who has the Remedia Chrome extension installed

And you can engage in debunking yourself.

CAUTION! Abusing the platform is not allowed, entering unverified, misleading or untrue content will result in the deletion of the entire account with all content

Canonical -> If you enter content that already exists somewhere (your property), you can enter a link and Remedia will try to enter the content in the provided fields.

Featured image -> Image that is displayed when you share an article on other social networks.

Write your title -> Enter the title of the article

The claim being reviewed -> Enter the claim here, but BEWARE! An assertion is not the entire statement someone has made, but something concise and unambiguous. Check the claim entry multiple times as each change will create a new claim in the system.

Claim made on -> date when someone published the claim.

After installing the Chrome extension, you can log in and use advanced functionalities. One of them is 'Dislike'.

By right-clicking on an article, the options provided by the Remedia extension are opened, by selecting Dislike, the article will become more transparent and less visible.

Your action will be visible to you and all people who follow you!

Alternate Title

1. Log in to the Remedia social network with a Google or Facebook account (link above right).

2. Install the Chrome extension (if you didn't)

4. Enter the email you used to open your Google or Facebook account. Submit.

5. After the input field appears, rewrite the code. Accept.

That's it! Now you can use the advanced functions of the Remedia Chrome extension.

Alternate Titles

Remedia's work so far:

Remedia, the best thing that happened to media!

On the Feed page, you can enter Status, Opinion and Claim Review

It is enough to enter the title, short description and content.

Below the fields for entering content, you will find fields for entering links. By entering page links in these fields, you 'show' the Chrome extension on which pages to display your content

Press Publish to publish your opinion. (It may be necessary to wait a moment while all links are generated)

Claim: "Ivermectin, Mebendazole i Fenbendazole Protokol za liječenje raka je objavljen i recenziran 19. rujna 2024." is False

Has beed claimed by:

Articles reviewing this claim:

Content you might like: